Exact Sciences Stock Insider Trading

Healthcare > Medical - Diagnostics & Research

Buy EXAS

*Your capital is at risk

$104.91

+0 (+0%)

At Close: Jun 22, 2026

EXACT Sciences Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 18.80. In total, the insiders bought 1.11M and sold 1.42M EXAS shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	18.80
● Buy	1.11M shares
● Sell	1.42M shares
35% Buy Activity Strong Negative Correlation
Sell Signal Low Confidence Mar 23, 2026 Analysis Breakdown: Weakened by a contradictory positive Insider Power Score. Partially supported by a negative historical correlation. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Feb 27, 2026 Buy	Restricted Stock Units M-Exempt	Conroy Kevin T President And CEO	CEO / President	27 786 Value: $2.87M
Feb 27, 2026 Buy	Common Stock M-Exempt	Conroy Kevin T President And CEO	CEO / President	18 143 Value: $1.88M
Feb 27, 2026 Sell	Common Stock F-InKind	Conroy Kevin T President And CEO	CEO / President	10 419 Value: $1.08M
Feb 27, 2026 Buy	Common Stock M-Exempt	Conroy Kevin T President And CEO	CEO / President	22 168 Value: $2.29M
Feb 27, 2026 Sell	Common Stock F-InKind	Conroy Kevin T President And CEO	CEO / President	13 060 Value: $1.35M
Feb 27, 2026 Buy	Common Stock M-Exempt	Conroy Kevin T President And CEO	CEO / President	27 786 Value: $2.87M
Feb 27, 2026 Buy	Stock Options (Right to Buy) M-Exempt	Condella Sarah EVP, Human Resources	Officer	3 900 Value: $19.6K
Feb 27, 2026 Sell	Common Stock F-InKind	Conroy Kevin T President And CEO	CEO / President	8 528 Value: $880.5K
Feb 27, 2026 Buy	Common Stock M-Exempt	Condella Sarah EVP, Human Resources	Officer	3 900 Value: $19.6K
Feb 27, 2026 Sell	Common Stock F-InKind	Condella Sarah EVP, Human Resources	Officer	1 913 Value: $197.8K
Feb 27, 2026 Buy	Restricted Stock Units M-Exempt	Conroy Kevin T President And CEO	CEO / President	22 168 Value: $2.29M
Feb 27, 2026 Buy	Restricted Stock Units M-Exempt	Conroy Kevin T President And CEO	CEO / President	18 143 Value: $1.88M
Feb 25, 2026 Buy	Restricted Stock Units A-Award	Bloomer Aaron EVP, Chief Financial Officer	C-Suite Officer	28 063 Value: $2.90M
Feb 25, 2026 Buy	Restricted Stock Units A-Award	Condella Sarah EVP, Human Resources	Officer	23 224 Value: $2.40M
Feb 25, 2026 Buy	Restricted Stock Units A-Award	Herriott James SVP, General Counsel & Sec	Officer	20 321 Value: $2.10M
Feb 25, 2026 Buy	Common Stock A-Award	Conroy Kevin T President And CEO	CEO / President	13 181 Value: $1.36M
Feb 25, 2026 Sell	Common Stock F-InKind	Conroy Kevin T President And CEO	CEO / President	6 196 Value: $641.0K
Feb 25, 2026 Buy	Restricted Stock Units A-Award	Conroy Kevin T President And CEO	CEO / President	154 829 Value: $16.0M
Feb 25, 2026 Buy	Restricted Stock Units A-Award	Baranick Brian EVP, Gm, Precision Oncology	Officer	28 063 Value: $2.90M
Feb 25, 2026 Buy	Restricted Stock Units A-Award	Orville Jacob A EVP, Gm, Screening	Officer	38 707 Value: $4.00M
Dec 24, 2025 Sell	Common Stock F-InKind	Baranick Brian EVP, Gm, Precision Oncology	Officer	14 938 Value: $1.52M
Dec 24, 2025 Buy	Common Stock A-Award	Baranick Brian EVP, Gm, Precision Oncology	Officer	29 416 Value: $2.99M
Dec 23, 2025 Sell	Common Stock F-InKind	Baranick Brian EVP, Gm, Precision Oncology	Officer	4 799 Value: $488.6K
Dec 23, 2025 Sell	Common Stock F-InKind	Baranick Brian EVP, Gm, Precision Oncology	Officer	7 539 Value: $767.6K
Dec 23, 2025 Sell	Common Stock F-InKind	Baranick Brian EVP, Gm, Precision Oncology	Officer	8 151 Value: $829.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT EXACT SCIENCES CORPORATION

Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for breast, prostate, and colon cancers; Oncotype Test, a tissue test delivering tumor profiling to aid th...

Read Full Profile Here